Instrumentation

WHITE PAPERS AND CASE STUDIES

• Dechlorination Of RO Feed Water In Power Station

  Plant Bowen, a coal-fired power station in Georgia, successfully implemented Atlantium's HOD UV technology to eliminate microbial growth and improve the performance of their reverse osmosis system. The HOD UV system removed chlorine, reduced maintenance costs, and extended the lifespan of membranes.

• Guiding GLP-1 Participants Through The Challenge Of Retention

  Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.

• Development To Large-Scale cGMP Production

  For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

• Avoiding Unplanned Outages In Water Treatment

  Maintenance professionals within water and wastewater Treatment facilities are as busy as ever. To keep up with growing demands on their time, they are always looking for ways to improve the reliability and maintenance requirements within their scope of responsibility.

• Aqua TruDense™ Provides Additional Capacity, Improves Settling, And Achieves Enhanced Nutrient Removal

  A densified sludge process can improve wastewater treatment by promoting larger, denser sludge particles. This enhances settling, improves nutrient removal, and increases treatment capacity.

• Drinking Water Disinfection In A New Hampshire Town

  The town of Hillsborough, NH chose Atlantium's HOD UV system to disinfect their drinking water due to its low disinfection by-products and reliable virus inactivation. Atlantium's UV technology is validated and offers stable and efficient water treatment solutions.

• How Compassion Shaped This Pediatric Rare Disease Trial

  Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study.

• Redefining Accessibility For Pediatric Patients

  Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.

• Propelling Glioblastoma Research: Orthotopic Model Solutions

  Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

• Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads

  Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

• Time-To-Manufacture Reduced By 30% Through Rapid Transfer Strategy

  Critical formulation deficiencies were solved through rapid batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.